Skip to main content

Advertisement

ADVERTISEMENT

Upper Tract Urothelial Cancer News

News
10/23/2024
The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
The molecular characteristics of primary and metastatic tumors in patients with upper tract urothelial carcinoma (UTUC) are mostly stable, suggesting that oncologists may be able to use analyses of primary tumor samples for molecular...
The molecular characteristics of...
10/23/2024
First Report Managed Care
News
10/10/2024
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and...
An American Urological...
10/10/2024
First Report Managed Care
News
09/03/2024
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.
Stereotactic MR-guided...
09/03/2024
First Report Managed Care

Advertisement

News
08/23/2024
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel therapy may be a viable alternative to bacillus Calmette-Guérin (BCG) for patients with high-risk non-muscle invasive bladder cancer (NMIBC), according to study results published in JAMA Network Open.
Gemcitabine and docetaxel...
08/23/2024
First Report Managed Care

Advertisement